Aura Biosciences Has Dosed The First Patient In The Global Phase 3 CoMpass Trial Evaluating The Safety And Efficacy Of Belzupacap Sarotalocan (Bel-sar) For The First-line Treatment Of Early-stage Choroidal Melanoma
Author: Benzinga Newsdesk | December 07, 2023 09:04am